Helen McIlleron Selected Research

Isoniazid (Ftivazide)

1/2022	Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosis.
1/2022	Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis.
1/2021	Effect of Isoniazid Intake on Ethionamide Pharmacokinetics and Target Attainment in Multidrug-Resistant Tuberculosis Patients.
1/2020	Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Pregnant South African Women with Tuberculosis and HIV.
1/2019	A Systematic Review on the Effect of HIV Infection on the Pharmacokinetics of First-Line Tuberculosis Drugs.
1/2019	Current research toward optimizing dosing of first-line antituberculosis treatment.
1/2019	Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis.
11/2017	A Review of Moxifloxacin for the Treatment of Drug-Susceptible Tuberculosis.
5/2017	Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.
1/2017	Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary Tuberculosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Helen McIlleron Research Topics

Disease

67	Tuberculosis (Tuberculoses) 10/2022 - 11/2005
17	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2022 - 07/2012
15	Pulmonary Tuberculosis 11/2018 - 07/2005
11	Body Weight (Weight, Body) 01/2021 - 04/2006
9	HIV Infections (HIV Infection) 12/2020 - 06/2009
4	Coinfection 05/2022 - 11/2014
4	Infections 01/2012 - 04/2006
3	Drug-Related Side Effects and Adverse Reactions 10/2016 - 11/2007
3	Immune Reconstitution Inflammatory Syndrome 12/2013 - 08/2007
2	Neutropenia 02/2015 - 11/2014
1	Malnutrition (Nutritional Deficiencies) 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2021
1	Psychotic Disorders (Schizoaffective Disorder) 04/2021
1	Sepsis (Septicemia) 01/2020
1	Hepatitis 01/2020
1	Hearing Loss (Hearing Impairment) 01/2020
1	Viremia 12/2016
1	Lipodystrophy 02/2016
1	Hypersensitivity (Allergy) 02/2016
1	Uveitis 11/2014
1	Nausea 01/2012
1	Diarrhea 01/2012
1	Kwashiorkor 06/2009
1	Opportunistic Infections (Opportunistic Infection) 08/2007
1	Falciparum Malaria (Plasmodium falciparum Malaria) 11/2006
1	Malaria 11/2006

Drug/Important Bio-Agent (IBA)

39	Pharmaceutical PreparationsIBA 10/2022 - 04/2006
39	Rifampin (Rifampicin)FDA LinkGeneric 05/2022 - 07/2005
21	Isoniazid (Ftivazide)FDA LinkGeneric 01/2022 - 04/2006
17	Pyrazinamide FDA LinkGeneric 01/2020 - 04/2006
12	Ritonavir (Norvir)FDA Link 05/2022 - 10/2010
12	Lopinavir FDA Link 05/2022 - 10/2010
11	Ethambutol (Myambutol)FDA LinkGeneric 12/2020 - 04/2006
5	Gatifloxacin (Zymar)FDA Link 11/2018 - 12/2007
4	abacavir (Ziagen)FDA Link 01/2022 - 02/2016
4	bedaquiline (R207910)IBA 01/2022 - 01/2014
4	Nevirapine (Viramune)FDA Link 12/2016 - 02/2008
3	Cycloserine (Seromycin)FDA Link 04/2021 - 11/2018
3	Moxifloxacin (Avelox)FDA Link 11/2018 - 11/2017
3	lopinavir-ritonavir drug combination (Kaletra)FDA Link 01/2018 - 01/2012
3	rifapentine (Priftin)FDA Link 11/2017 - 07/2005
3	Rifabutin (Ansamycin)FDA Link 01/2016 - 11/2014
2	efavirenz (Sustiva)FDA Link 01/2022 - 01/2015
2	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2022 - 10/2021
2	terizidoneIBA 04/2021 - 10/2020
2	Ethionamide (Trecator-SC)FDA Link 01/2021 - 01/2020
2	RifamycinsIBA 11/2017 - 06/2015
2	Protease Inhibitors (Protease Inhibitor)IBA 06/2015 - 11/2014
1	Aminosalicylic Acid (Rezipas)FDA Link 01/2022
1	Contraceptive Agents (Contraceptives)IBA 10/2021
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 04/2021
1	Kanamycin FDA Link 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2020
1	Drug CombinationsIBA 01/2019
1	pretomanidIBA 11/2017
1	QuinolonesIBA 11/2017
1	Zidovudine (Retrovir)FDA LinkGeneric 02/2016
1	Cytochrome P-450 CYP3AIBA 02/2015
1	OPC-67683IBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 02/2013
1	Lamivudine (Epivir)FDA Link 08/2012
1	FluoroquinolonesIBA 07/2012
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 07/2012
1	EnzymesIBA 04/2012
1	Transaminases (Aminotransferases)IBA 01/2012
1	Interferon-gamma (Interferon, gamma)IBA 11/2007
1	AntigensIBA 11/2007
1	ArtesunateIBA 11/2006
1	Antimalarials (Antimalarial Agents)IBA 11/2006
1	artenimol (dihydroartemisinin)IBA 11/2006

Therapy/Procedure

19	Therapeutics 01/2022 - 08/2007
7	Drug Therapy (Chemotherapy) 11/2018 - 11/2007
2	Duration of Therapy 11/2018 - 06/2015
1	Intramuscular Injections 01/2022
1	Injections 10/2021
1	Aftercare (After-Treatment) 10/2020
1	Art Therapy 10/2016
1	Drug Tapering 01/2012